Evidence map›Paper›PMID 19632058›Full record

ArticleMedical hypotheses2009

Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder.

Brian E Perron, Matthew O Howard, Michael G Vaughn, Christopher N Jarman

Abstract read
In one paragraph

Article in Medical hypotheses, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Difluoroethane Inhalant Abuse, Skeletal Fluorosis, and Withdrawal.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2020
    Article
  3. Volatile substance misuse: an updated review of toxicity and treatment.Clinical reviews in allergy & immunology · 2014
    Review
  4. Review
  5. Inhalant use and inhalant use disorders in the United States.Addiction science & clinical practice · 2011
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Brian E PerronUniversity of Michigan, School of Social Work, 1080 S University Avenue, Ann Arbor, MI 48109, United States. beperron@umich.edu
Matthew O Howard
Michael G Vaughn
Christopher N Jarman
University of Michigan–Ann Arbor · USSaint Louis University · USUniversity of North Carolina at Chapel Hill · US

Funding

Natural History, Comorbid Mental Disorders, and Consequences of Inhalant AbuseR01DA021405 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOWARD, MATTHEW O · 2007 to 2009
$567k
Symptoms and Structure of Inhalant Use DisordersR03DA027832 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PERRON, BRIAN E · 2009 to 2010
$154k
A Population-based Study of Emergency Room Care and Drug UseR03AA019575 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PERRON, BRIAN E · 2009 to 2010
$77k
NIAAA NIH HHS R03 AA019575NIDA NIH HHS DA021405NIDA NIH HHS R01 DA021405NIDA NIH HHS R03 DA027832
6 · The paper itself

Abstract

Inhalant use is the intentional inhalation of vapors from commercial products or specific chemical agents for the purpose of achieving intoxication. Inhalants are among the most common and pernicious forms of substance use and the least studied of the major drugs. Diagnosis of inhalant dependence, according to the DSM-IV [Weintraub E, Gandhi D, Robinson C. Medical complications due to mothball abuse. South Med J 2000;93:427-9] excludes inhalant withdrawal symptoms, as expert opinion has suggested that an inhalant withdrawal syndrome is neither common nor clinically significant. This article draws from multiple sources of data to suggest that withdrawal symptoms can be part of inhalant dependence and are clinically significant. This hypothesis needs rigorous evaluation to ensure the diagnostic validity of inhalant use disorders.

Indexed as

Inhalation ExposureSubstance Withdrawal SyndromeHumansSubstance-Related Disorders

Identifiers

PMID19632058
PMCPMC2787661
OpenAlexW2072033776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.